Bayocot, Lani P.

HRN: 23-69-03  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2023
CEFAZOLIN 1GM (VIAL)
10/15/2023
10/16/2023
IV
2g
PTOR
Pelvic Organ Prolapse For Vaginal Hysterectomy
Waiting Final Action 
10/16/2023
CEFAZOLIN 1GM (VIAL)
10/16/2023
10/17/2023
IV
1g
Q8h
S/p Vaginal Hysterectomy
Waiting Final Action 
10/16/2023
CEFUROXIME 500MG (TAB)
10/16/2023
10/22/2023
PO
500mg
BID
S/p Vaginal Hysterectomy
Waiting Final Action 
01/19/2024
CEFTRIAXONE 1G (VIAL)
01/19/2024
01/25/2024
IV
2g
OD
Complicated UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: